Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA

Research output: Contribution to journalLetterpeer-review

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)237-238
Number of pages2
JournalAmerican journal of hematology
Volume86
Issue number2
DOIs
StatePublished - Feb 2011

ASJC Scopus subject areas

  • Hematology

Cite this